Molecularly guided therapy may improve outcomes in patients with unfavourable cancer of unknown primary compared with standard chemotherapy
1. The use of molecularly guided therapy (MGT) was associated with significantly improved progression-free survival (PFS) compared with standard platinum-based ...









